Martin T Küenzi

Title: Martin T Küenzi: Innovator in Cobalamin Derivatives

Introduction

Martin T Küenzi is an accomplished inventor based in Muttenz, Switzerland, known for his innovative contributions to the field of medicinal chemistry. His notable work has led to advancements in the diagnosis and treatment of abnormal cellular proliferation.

Latest Patents

Küenzi holds a significant patent entitled "Cobalamine derivatives useful for diagnosis and treatment of abnormal cellular proliferation." This invention encompasses cobalamin derivatives that exhibit low or no binding affinity to the transport protein transcobalamin II (TCII), while still acting effectively as a vitamin B12 substitute. These derivatives optionally carry therapeutic and/or diagnostic agents, including radioactive metals. The unique properties of these compounds lead to a significantly reduced accumulation rate in blood and benign organs, such as the kidneys and liver, compared to neoplastic tissues, allowing for more efficient elimination from the bloodstream.

Career Highlights

Throughout his career, Martin T Küenzi has been affiliated with prominent organizations, including Solidago AG and the University of Zurich. His work has not only contributed to innovative developments in medical treatments but has also underscored the importance of research and development in pharmacology.

Collaborations

Küenzi has collaborated with notable professionals in the industry, including Hans-Jörg Treichler and Roger Alberto. These collaborations have facilitated knowledge sharing and enhanced research outcomes, leading to impactful advancements in the medical field.

Conclusion

Martin T Küenzi's contributions to the development of cobalamin derivatives represent a significant step forward in the diagnosis and treatment of neoplastic diseases and infections in mammals. His innovative approach and commitment to research continue to inspire advancements in medicine, illustrating the vital role of inventors in the scientific community.